References
- Pyörälä K, De Backer G, Graham I, Poole-Wilson P, Wood D. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J 1994; 15: 1300–31
- The Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastitin Survival Study (4S). Lancet 1994; 344: 1383–9
- Shepherd J, Cobbe S M, Ford I, Isles C G, Lorimer A R, Mac Farlane P W, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. New Engl J Med 1995; 333: 1301–7
- Collins R, Peto R, Mac Mahon S, Hebert P, Fiebach N H, Eberlein K A, et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827–38
- Appleyard M, Hansen A T, Jensen G, Schnohr P, Nyboe J. The Copenhagen City Heart Study. Østerbroundersøgelsen. A book of tables with data from the first examination (1976–78) and a five year follow-up (1981–83). The Copenhagen City Heart Study Group. Scand J Soc Med 1989; 1–160, Suppl 41
- Nordestgaard B G, Reeler S, Steffensen R, Tybjærg-Hansen A. Clinical expression in the heterozygote state of the Gly188 → Glu mutation in the lipoprotein lipase gene: screening among 1000 heart patients and 5400 persons from the general population (The Copenhagen City Heart Study). Atherosclerosis 1994; 109: 205
- Brunzell J. Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. The metabolic and molecular bases of inherited disease, 7th ed., C Scriver, A Beaudet, W Sly, D Valle. McGraw-Hill Inc., New York 1995; 1913–32
- Cambien F, Poirier O, Lecerf L, Evans A, Cambou J P, Arveiler D, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641–4
- Lindpaintner K, Pfeffer M A, Kreutz R, Stampfer M J, Grodstein F, La Motte F, et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. New Engl J Med 1995; 332: 706–11
- Agerholm-Larsen B, Nordestgaard B G, Steffensen R, Sørensen T IA, The Copenhagen City Heart Study Group, Tybjærg-Hansen A. The angiotensin-converting-enzyme gene polymorphism fails to predict coronary heart disease in a case-cohort study of 7300 individuals. Circulation 1995; 92: 1800, Suppl. I